Literature DB >> 18948764

Familial thyroid carcinoma: a diagnostic algorithm.

Jorge Dotto1, Vânia Nosé.   

Abstract

Thyroid carcinomas derived from follicular cells are the most common endocrine malignancies, and papillary thyroid carcinoma (PTC) is the most common type. Although, the majority of papillary and follicular thyroid carcinomas (FTCs) are sporadic, familial forms have been described in recent years. Familial syndromes are classified into familial medullary thyroid carcinoma and familial nonmedullary thyroid carcinoma. Multifocal papillary carcinoma is the most frequent presentation of familial nonmedullary thyroid carcinoma, and based on clinico-pathologic findings it is divided into 2 groups. The first includes familial syndromes characterized by a predominance of nonthyroidal tumors, such as familial adenomatous polyposis, PTEN-hamartoma tumor syndrome, Carney complex type 1, and Werner syndrome. The second group includes familial syndromes characterized by a predominance of NMTC, such as pure familial (f) PTC with or without oxyphilia, fPTC with papillary renal cell carcinoma, and fPTC with multinodular goiter. Medullary thyroid carcinoma is derived from calcitonin-producing C cells. The familial form accounts for 20% to 25% of cases, and is usually a component of multiple endocrine neoplasia (MEN) IIA or IIB, or presents as pure familial medullary thyroid carcinoma syndrome. C-cell hyperplasia is the precursor lesion of these heritable syndromes. Some characteristic morphologic findings should alert the pathologist of a possible familial cancer syndrome, which may lead to further molecular genetic evaluation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18948764     DOI: 10.1097/PAP.0b013e31818a64af

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  12 in total

Review 1.  Familial follicular cell tumors: classification and morphological characteristics.

Authors:  Vânia Nosé
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

2.  Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.

Authors:  Tae-Yon Sung; Yu-mi Lee; Jong Ho Yoon; Ki-Wook Chung; Suck Joon Hong
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

3.  A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer.

Authors:  Carolina Pires; Inês Jorge Marques; Daniela Dias; Ana Saramago; Valeriano Leite; Branca Maria Cavaco
Journal:  Endocrine       Date:  2021-03-08       Impact factor: 3.633

4.  The clinical management in familial adenomatous polyposis deserves continuous monitoring for thyroid carcinoma.

Authors:  Stefano Crippa; Piercarlo Saletti; Jessica Barizzi; Luca Mazzucchelli
Journal:  BMJ Case Rep       Date:  2012-11-15

5.  [Familial thyroid carcinomas].

Authors:  K W Schmid; S Ting; S-Y Sheu
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 6.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

7.  Familial papillary thyroid carcinoma: a retrospective analysis.

Authors:  Thomas J McDonald; Albert A Driedger; Bertha M Garcia; Stanislaus H M Van Uum; Irina Rachinsky; Vijaya Chevendra; Daniel Breadner; Richard Feinn; Stephen J Walsh; Carl D Malchoff
Journal:  J Oncol       Date:  2011-10-25       Impact factor: 4.375

8.  Familial follicular cell-derived thyroid carcinoma.

Authors:  Eun Ju Son; Vânia Nosé
Journal:  Front Endocrinol (Lausanne)       Date:  2012-05-03       Impact factor: 5.555

9.  Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis.

Authors:  Vania Nosé; Ozgur Mete; Baris Boyraz; Peter M Sadow; Sylvia L Asa; Dora Dias-Santagata
Journal:  Endocr Pathol       Date:  2021-05-21       Impact factor: 4.056

Review 10.  RET gene abnormalities and thyroid disease: who should be screened and when.

Authors:  Behrouz Salehian; Raynald Samoa
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.